This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Araten, D. J. Articles by Luzzatto, L. Search for Related Content PubMed PubMed Citation Articles by Araten, D. J. Articles by Luzzatto, L.

A Quantitative Measurement of the Human Somatic Mutation Rate

¹ Division of Hematology and ² Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; ³ Istituto Nazionale per la Ricerca sul Cancro; and ⁴ University of Genova, Genoa, Italy

Requests for reprints: David J. Araten, Division of Hematology, NYU Cancer Institute, 160 East 34^th Street, New York, NY 10016. Phone: 212-731-5186; Fax: 212-731-5540; E-mail: David.Araten{at}nyumc.org.

The mutation rate (µ) is a key biological feature of somatic cells that determines risk for malignant transformation, and it has been exceedingly difficult to measure in human cells. For this purpose, a potential sentinel is the X-linked PIG-A gene, because its inactivation causes lack of glycosylphosphatidylinositol-linked membrane proteins. We previously found that the frequency (f) of PIG-A mutant cells can be measured accurately by flow cytometry, even when f is very low. Here we measure both f and µ by culturing B-lymphoblastoid cell lines and first eliminating preexisting PIG-A mutants by flow sorting. After expansion in culture, the frequency of new mutants is determined by flow cytometry using antibodies specific for glycosylphosphatidylinositol-linked proteins (e.g., CD48, CD55, and CD59). The mutation rate is then calculated by the formula µ = f/d, where d is the number of cell divisions occurring in culture. The mean µ in cells from normal donors was 10.6 x 10^–7 mutations per cell division (range 2.4 to 29.6 x 10^–7). The mean µ was elevated >30-fold in cells from patients with Fanconi anemia (P < 0.0001), and µ varied widely in ataxia-telangiectasia with a mean 4-fold elevation (P = 0.002). In contrast, µ was not significantly different from normal in cells from patients with Nijmegen breakage syndrome. Differences in µ could not be attributed to variations in plating efficiency. The mutation rate in man can now be measured routinely in B-lymphoblastoid cell lines, and it is elevated in cancer predisposition syndromes. This system should be useful in evaluating cancer risk and in the design of preventive strategies.

This article has been cited by other articles:

				C. Hornsby, K. M. Page, and I. Tomlinson The in Vivo Rate of Somatic Adenomatous Polyposis Coli Mutation Am. J. Pathol., April 1, 2008; 172(4): 1062 - 1068. [Abstract] [Full Text] [PDF]

				S. Jones, W.-d. Chen, G. Parmigiani, F. Diehl, N. Beerenwinkel, T. Antal, A. Traulsen, M. A. Nowak, C. Siegel, V. E. Velculescu, et al. Comparative lesion sequencing provides insights into tumor evolution PNAS, March 18, 2008; 105(11): 4283 - 4288. [Abstract] [Full Text] [PDF]

				A. Traulsen, J. M. Pacheco, and D. Dingli On the Origin of Multiple Mutant Clones in Paroxysmal Nocturnal Hemoglobinuria Stem Cells, December 1, 2007; 25(12): 3081 - 3084. [Abstract] [Full Text] [PDF]

				J. V. Lopes, J. M. Pacheco, and D. Dingli Acquired hematopoietic stem-cell disorders and mammalian size Blood, December 1, 2007; 110(12): 4120 - 4122. [Abstract] [Full Text] [PDF]

				J. M. Hinz, P. B. Nham, S. S. Urbin, I. M. Jones, and L. H. Thompson Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis Nucleic Acids Res., June 28, 2007; 35(11): 3733 - 3740. [Abstract] [Full Text] [PDF]

				D. J. Araten and L. Luzzatto The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH) Blood, July 15, 2006; 108(2): 734 - 736. [Abstract] [Full Text] [PDF]

				Measurement of the Human Mutation Rate Cancer Res., November 15, 2005; 65(22): 10635 - 10635. [Full Text]